Monday, March 23, 2026 | 09:20 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma Ltd News

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt
Updated On : 23 Mar 2026 | 9:58 AM IST

Demerger buzz, semaglutide injection plans sees Natco Pharma shares jump 4%

Demerger: Natco Pharma shares gained nearly 4 per cent in trade on Friday ahead of next week's board meeting to consider a demerger proposal

Demerger buzz, semaglutide injection plans sees Natco Pharma shares jump 4%
Updated On : 20 Mar 2026 | 11:14 AM IST

Natco rallies 5%, nears 52-week high; what's driving pharma stock?

In the past four trading days, the stock price of Natco Pharma has surged 10 per cent after the company announced the launch of Pomalidomide Capsules (generic of Pomalyst) in the US market.

Natco rallies 5%, nears 52-week high; what's driving pharma stock?
Updated On : 10 Mar 2026 | 10:02 AM IST

Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US

The buying on the counter came after Natco Pharma, along with Breckenridge Pharmaceutical, launched Pomalidomide Capsules, a generic version of Pomalyst by Celgene, in the US market.

Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US
Updated On : 04 Mar 2026 | 10:12 AM IST

Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes

At 01:13 PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.

Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes
Updated On : 24 Feb 2026 | 1:59 PM IST

Natco Pharma zooms 11% on getting CDSCO approval for Semaglutide injections

The buying on the counter came after Natco Pharma received approval from the Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India

Natco Pharma zooms 11% on getting CDSCO approval for Semaglutide injections
Updated On : 16 Feb 2026 | 10:29 AM IST

Stocks to Watch today: Coal India, SpiceJet, HUL, Biocon, Infosys, IRCTC

Stocks to watch today, Friday, February 13, 2026: Market participants will keep an eye on SpiceJet, Coal India, Biocon, Infosys, Mishra Dhatu Nigam, Indraprastha Gas share prices today

Stocks to Watch today: Coal India, SpiceJet, HUL, Biocon, Infosys, IRCTC
Updated On : 13 Feb 2026 | 8:18 AM IST

Midcap Marico, 5 smallcap stocks with 'Double Bottom' pattern on charts

Among smallcaps - Natco Pharma, Neuland Laboratories, Inox India, Welspun Living and GE Shipping shares have witnessed the formation of 'Double Bottom' pattern on the technical charts.

Midcap Marico, 5 smallcap stocks with 'Double Bottom' pattern on charts
Updated On : 15 Dec 2025 | 11:00 AM IST

Natco Pharma share price rises 5% on rating update; check key details here

Natco Pharma, in a regulatory filing, has informed the exchanges that the credit rating agency ICRA Limited has reaffirmed and assigned credit ratings for Natco Pharma's various debt instruments.

Natco Pharma share price rises 5% on rating update; check key details here
Updated On : 01 Dec 2025 | 11:11 AM IST

Natco Pharma shares drop as Chennai plant receives USFDA observations

Natco Pharma shares fell 2 per cent as it received seven observations in the Form-483 from the US Food and Drug Administration

Natco Pharma shares drop as Chennai plant receives USFDA observations
Updated On : 24 Nov 2025 | 10:08 AM IST

Tejas, Vedant Fashion: Will laggards of Samvat 2081 recover in Samvat 2082?

Among the Nifty 500 constituents, Tejas Networks (down 56 per cent), Praj Industries (down 54 per cent), and Vedant Fashions (down 52 per cent) were among the worst hit

Tejas, Vedant Fashion: Will laggards of Samvat 2081 recover in Samvat 2082?
Updated On : 16 Oct 2025 | 9:41 AM IST

Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal

The buying on the counter came after the Delhi High Court dismissed an appeal by F. Hoffmann-La Roche AG, removing the last legal hurdle for Natco Pharma to launch a generic version of Risdiplam

Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal
Updated On : 10 Oct 2025 | 11:08 AM IST

Delhi HC dismisses Roche's plea, allows Natco to sell generic Risdiplam

The court upheld a previous order denying Roche's injunction plea, citing public interest and affordability in treatment for spinal muscular atrophy patients

Delhi HC dismisses Roche's plea, allows Natco to sell generic Risdiplam
Updated On : 09 Oct 2025 | 8:25 PM IST